For: | Wu ZW, Sha Y, Chen Q, Hou J, Sun Y, Lu WK, Chen J, Yu LJ. Novel intergenic KIF5B-MET fusion variant in a patient with gastric cancer: A case report. World J Clin Cases 2021; 9(14): 3350-3355 [PMID: 34002144 DOI: 10.12998/wjcc.v9.i14.3350] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i14/3350.htm |
Number | Citing Articles |
1 |
Dantong Sun, Xiaoming Xing, Yongjie Wang, Helei Hou. MET fusions are targetable genomic variants in the treatment of advanced malignancies. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01454-0
|
2 |
Qiangqiang Zhong, Wenbo Hong, Lina Xiong. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer. Aging 2024; doi: 10.18632/aging.205694
|
3 |
Pei Yuan, Xuemin Xue, Tian Qiu, Jianming Ying. MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359231221910
|